Autosomal Dominant Polycystic Kidney Disease: Review and Management Update - European Medical Journal

Autosomal Dominant Polycystic Kidney Disease: Review and Management Update

Nephrology
Download PDF
Author:
*Víctor Martínez
Disclosure:

The author declares no potential conflict of interest.

Received:
21.02.14
Accepted:
08.05.14
Citation:
EMJ Nephrol. ;1[1]:61-66. DOI/10.33590/emjnephrol/10310938. https://doi.org/10.33590/emjnephrol/10310938.
Keywords:
Autosomal dominant polycystic kidney disease (ADPKD), diagnosis, cysts complications, renal disease progression, extrarenal manifestations.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited nephropathy. Initially, it is characterised by the growth of renal cysts. Later, progressive deterioration of renal function determines the prognosis of ADPKD, depending on the main factors of progression (genetic, renal volume, and hypertension). Ultrasonography is the diagnostic technique of choice in the screening for relatives of ADPKD patients. Due to the absence of specific treatment it is necessary, in many cases, to start with renal replacement therapy. ADPKD can also be associated with extrarenal manifestations, mainly polycystic liver disease and cerebral aneurysms, which contribute to increased morbidity and mortality of these patients.

Please view the full content in the pdf above.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.